BBlogFlow

Epidemiological alert Chikungunya - 10 February 2026 - Pan American Health Organization (PAHO)

·Feb 10, 2026
Source: Pan American Health Organization (PAHO)
Read the original article

This story deserves to be shared

Send it to someone who'd care, or post it on your networks.

Facebook Twitter Email

This article is an excerpt. To read the full content, visit the original source. Pan American Health Organization (PAHO)

Reactions

0 comments

No comments yet. Be the first to share your thoughts!

Facebook Twitter

Related articles

GLP-1 Drugs and Mental Health: Effects on Depression and Anxiety - News-Medical

IntroductionDepression and anxiety outcomesEffects on reward-related and behavioral disordersWhy study findings differEffects in severe mental illnessSafety concerns and adverse psychiatric signalsLimitations of current evidenceReferences Medicines that change appetite also influence brain circuits that govern emotion and reward, raising questions about their role in psychiatric care.

News-Medical·

How GLP-1 Medications Affect PCOS, Fertility, and Pregnancy - News-Medical

IntroductionPathophysiology of PCOS and reproductive dysfunctionMechanistic rationale for GLP-1 in fertility improvementEffects on metabolic and hormonal parametersEvidence on fertility and pregnancy outcomesPreclinical and translational evidenceSafety and pregnancy considerationsLimitations and research gapsReferences Weight, insulin, and ovarian hormones connect PCOS with infertility, raising questions about where GLP-1 therapies could fit in reproductive care.

News-Medical·